We are live on ! Find out more
PCRX icon

Pacira BioSciences
PCRX

239 hedge funds and large institutions have $1.24B invested in Pacira BioSciences in 2025 Q3 according to their latest regulatory filings, with 37 funds opening new positions, 67 increasing their positions, 95 reducing their positions, and 30 closing their positions.

New
Increased
Maintained
Reduced
Closed

374% more call options, than puts

Call options by funds: $3.13M | Put options by funds: $661K

100% more funds holding in top 10

Funds holding in top 10: 1 → 2 (+1)

23% more first-time investments, than exits

New positions opened: 37 | Existing positions closed: 30

3% more funds holding

Funds holding: 233 → 239 (+6)

2% more capital invested

Capital invested by funds: $1.21B → $1.24B (+$28.4M)

2.41% less ownership

Funds ownership: 109.17% → 106.76% (-2.4%)

29% less repeat investments, than reductions

Existing positions increased: 67 | Existing positions reduced: 95

Holders
239
Holders Change
+6
Holders Change %
+2.58%
% of All Funds
3.14%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
37
Increased
67
Reduced
95
Closed
30
Calls
$3.13M
Puts
$661K
Net Calls
+$2.47M
Net Calls Change
-$2.36M

Top Buyers

1
DPCM
Doma Perpetual Capital Management
Florida
+$22M
2
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$10.1M
3
American Century Companies
American Century Companies
Missouri
+$4.81M
4
Morgan Stanley
Morgan Stanley
New York
+$4.73M
5
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
+$4.16M

Top Sellers

1
PCH
Polar Capital Holdings
United Kingdom
-$21.8M
2
BlackRock
BlackRock
New York
-$11.3M
3
EC
EcoR1 Capital
California
-$10.9M
4
Millennium Management
Millennium Management
New York
-$10.9M
5
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
-$8.16M
Name Holding Trade Value Shares
Change 		Change in
Stake
SBH
101
Segall Bryant & Hamill
Illinois
$765K -$2.01K -82 -0.3%
New York State Teachers Retirement System (NYSTRS)
102
New York State Teachers Retirement System (NYSTRS)
New York
$722K -$19.6K -800 -3%
MIM
103
MetLife Investment Management
New Jersey
$710K – – –
DekaBank Deutsche Girozentrale
104
DekaBank Deutsche Girozentrale
Germany
$692K – – –
LPL Financial
105
LPL Financial
California
$676K -$1.01M -40,977 -61%
Creative Planning
106
Creative Planning
Kansas
$658K -$5.4K -220 -0.9%
SOADOR
107
State of Alaska Department of Revenue
Alaska
$651K -$55.1K -2,243 -8%
SEI Investments
108
SEI Investments
Pennsylvania
$646K -$7K -285 -1%
IMRF
109
Illinois Municipal Retirement Fund
Illinois
$626K -$52.9K -2,153 -8%
Janus Henderson Group
110
Janus Henderson Group
United Kingdom
$601K – – –
YIH
111
Y-Intercept (HK)
Hong Kong
$575K +$253K +10,306 +86%
Mirae Asset Global ETFs Holdings
112
Mirae Asset Global ETFs Holdings
Hong Kong
$551K -$94.4K -3,842 -15%
Manulife (Manufacturers Life Insurance)
113
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$547K -$41.9K -1,706 -7%
LSERS
114
Louisiana State Employees Retirement System
Louisiana
$533K -$22.1K -900 -4%
VA
115
Vident Advisory
Georgia
$528K +$55.4K +2,255 +12%
JF
116
Jump Financial
Illinois
$527K +$502K +20,458 New
QT
117
Quantbot Technologies
New York
$526K +$501K +20,408 New
BF
118
BOK Financial
Oklahoma
$514K -$663 -27 -0.1%
VOYA Investment Management
119
VOYA Investment Management
Georgia
$511K +$178K +7,241 +57%
DFCM
120
Dark Forest Capital Management
Puerto Rico
$504K -$1.02M -41,670 -68%
Capstone Investment Advisors
121
Capstone Investment Advisors
New York
$494K +$471K +19,171 New
Tudor Investment Corp
122
Tudor Investment Corp
Connecticut
$480K +$458K +18,637 New
Nomura Holdings
123
Nomura Holdings
Japan
$477K -$2.47M -100,407 -84%
Ensign Peak Advisors
124
Ensign Peak Advisors
Utah
$472K -$66.3K -2,700 -13%
SCM
125
Sterling Capital Management
North Carolina
$457K +$43.6K +1,776 +11%
3 4
5
6 7

PCRX Hedge Fund Activity: Q3 2025 in Review

239 of the 7,619 institutional investors tracked by Wall St. Rank reported a position in Pacira BioSciences (PCRX) for Q3 2025, worth a combined $1.24B — up 2.3% from $1.21B a quarter earlier.

Buyers outnumbered sellers: 37 funds opened new PCRX positions and 30 closed out — a net gain of 7 holders — while 67 added to existing stakes and 95 trimmed.

The largest buyer was Doma Perpetual Capital Management, adding an estimated $22M. The largest seller was Polar Capital Holdings, exiting entirely with an estimated $21.8M sold.

  • 239 institutional investors held Pacira BioSciences (PCRX) as of Q3 2025, up from 233 in Q2 2025.
  • Funds reported $1.24B of Pacira BioSciences stock for Q3 2025, up 2.3% quarter-over-quarter.
  • 37 funds opened new Pacira BioSciences positions in Q3 2025 and 30 closed out, a net change of +7 holders.
  • The largest Pacira BioSciences buyer in Q3 2025 was Doma Perpetual Capital Management, an estimated $22M added.
  • The largest Pacira BioSciences seller in Q3 2025 was Polar Capital Holdings, an estimated $21.8M sold.

Based on aggregated 13F filings for Q3 2025.